Literature DB >> 7590049

Changes in portal hypertensive gastropathy after endoscopic variceal sclerotherapy or ligation: an endoscopic observation.

M C Hou1, H C Lin, C H Chen, B I Kuo, C L Perng, F Y Lee, S D Lee.   

Abstract

To determine the effect of endoscopic variceal sclerotherapy or ligation on portal hypertensive gastropathy, 90 cirrhotic patients with esophageal variceal bleeding were randomized to receive sclerotherapy (n = 44) or ligation (n = 46). Follow-up endoscopic observations of the gastric mucosa were recorded at 3-month intervals after variceal eradication. Clinical characteristics in both groups were similar. Probability for a change in the severity of portal hypertensive gastropathy was not related to method of eradication. Most cases of portal hypertensive gastropathy that changed in severity returned to baseline status with time, but the return was faster after ligation than after sclerotherapy. According to the results of multivariate analyses, sclerosant volume was the only factor associated with a significant difference between the group with static gastropathy (n = 15) and that with dynamic change in gastropathy (n = 23) after sclerotherapy. No relevant factors were found in the patients receiving ligation. We conclude that changes in the severity of portal hypertensive gastropathy after endoscopic variceal sclerotherapy or ligation are reversible. Most cases of gastropathy return to baseline status sooner or later.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7590049     DOI: 10.1016/s0016-5107(95)70070-6

Source DB:  PubMed          Journal:  Gastrointest Endosc        ISSN: 0016-5107            Impact factor:   9.427


  11 in total

Review 1.  Portal hypertensive gastropathy and gastric antral vascular ectasia (GAVE) syndrome.

Authors:  K W Burak; S S Lee; P L Beck
Journal:  Gut       Date:  2001-12       Impact factor: 23.059

2.  Portal hypertensive gastropathy: A systematic review of the pathophysiology, clinical presentation, natural history and therapy.

Authors:  Mihajlo Gjeorgjievski; Mitchell S Cappell
Journal:  World J Hepatol       Date:  2016-02-08

3.  Effects of esophageal varice eradication on portal hypertensive gastropathy and fundal varices: a retrospective and comparative study.

Authors:  Osman Yüksel; Seyfettin Köklü; Mehmet Arhan; Omer Faruk Yolcu; Ibrahim Ertuğrul; Bülent Odemiş; Emin Altiparmak; Burhan Sahin
Journal:  Dig Dis Sci       Date:  2006-01       Impact factor: 3.199

4.  Influence of extravariceal collateral channel pattern on recurrence of esophageal varices after sclerotherapy.

Authors:  T Sakai; T Iwao; K Oho; A Toyonaga; K Tanikawa
Journal:  J Gastroenterol       Date:  1997-12       Impact factor: 7.527

5.  Portal hypertensive gastropathy after variceal eradication: more bleeding risk or just more reddening?

Authors:  Massimo Primignani; Giulia Tosetti
Journal:  Hepatol Int       Date:  2016-06-09       Impact factor: 6.047

Review 6.  Management of gastropathy and gastric vascular ectasia in portal hypertension.

Authors:  Cristina Ripoll; Guadalupe Garcia-Tsao
Journal:  Clin Liver Dis       Date:  2010-05       Impact factor: 6.126

Review 7.  Management of varices in patients with cirrhosis.

Authors:  Julia O'Brien; Christos Triantos; Andrew K Burroughs
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2013-04-02       Impact factor: 46.802

8.  Effect of endoscopic variceal obliteration by band ligation on portal hypertensive gastro-duodenopathy: endoscopic and pathological study.

Authors:  Reda Elwakil; Ashraf Mohammad Al Breedy; Hoda Hassan Abou Gabal
Journal:  Hepatol Int       Date:  2016-03-01       Impact factor: 6.047

9.  Treatment of gastropathy and gastric antral vascular ectasia in patients with portal hypertension.

Authors:  Cristina Ripoll; Guadalupe Garcia-Tsao
Journal:  Curr Treat Options Gastroenterol       Date:  2007-12

Review 10.  Pathogenesis of portal hypertensive gastropathy: translating basic research into clinical practice.

Authors:  Rafael F Perini; Paula R S Camara; Jose G P Ferraz
Journal:  Nat Clin Pract Gastroenterol Hepatol       Date:  2009-02-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.